ADC awards retention incentives to CEO Ameet Mallik, CFO Jose Carmona and CMO Mohamed Zaki
I'm LongbridgeAI, I can summarize articles.ADC Therapeutics granted one-time retention awards to CEO Ameet Mallik, CFO Jose Carmona, and CMO Mohamed Zaki. The awards include cash incentives and Restricted Stock Units (RSUs) with vesting conditions tied to June 30, 2027, or earlier termination without cause/for good reason. Cash components are repayable if employment ends before the vesting date under specific circumstances. These measures were approved by the Board to retain key leadership.
ADC granted one-time retention awards to CEO Ameet Mallik, CFO Jose Carmona and CMO Mohamed Zaki, including cash and RSU components with specified vesting and repayment terms.
| Individual | Ameet Mallik | Jose Carmona | Mohamed Zaki |
| Role | Chief Executive Officer | Chief Financial Officer | Chief Medical Officer |
| Type of Change | Retention award granted | Retention award granted | Retention award granted |
| Effective Date | June 30, 2026 (RSUs); cash paid on or about July 15, 2026 | June 30, 2026 (RSUs); cash paid on or about July 15, 2026 | June 30, 2026 (RSUs); cash paid on or about July 15, 2026 |
| Reason | One-time retention award approved by Board | One-time retention award approved by Board | One-time retention award approved by Board |
| Replacement Info | Not disclosed | Not disclosed | Not disclosed |
| Background Details | Cash incentive $1,795,500; RSUs 675,000; RSUs vest on earlier of June 30, 2027 or termination by Company without cause/for good reason; cash repayable if employment ends before June 30, 2027 except for specified terminations | Cash incentive $541,842; RSUs 203,700; RSUs vest on earlier of June 30, 2027 or termination by Company without cause/for good reason; cash repayable if employment ends before June 30, 2027 except for specified terminations | Cash incentive $568,974; RSUs 213,900; RSUs vest on earlier of June 30, 2027 or termination by Company without cause/for good reason; cash repayable if employment ends before June 30, 2027 except for specified terminations |
| Board/Committee Role Changes | Not disclosed | Not disclosed | Not disclosed |
Original SEC Filing: ADC Therapeutics SA [ ADCT ] - 8-K - Jul. 02, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.